Cited by 477Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Open access

Maccioni, Ricardo B, Muñoz, Juan P, Barbeito, Luis·2001·Archives of Medical Research

DOI 10.1016/s0188-4409(01)00316-2

Open this paper in CoChat — free account

Abstract

Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs). Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Two main protein kinases have been shown to be involved in anomalous tau phosphorylations: the cyclin-dependent kinase Cdk5 and glycogen synthase kinase GSK3beta. Cdk5 plays a critical role in brain development and is associated with neurogenesis as revealed by studies in brain cells in culture and neuroblastoma cells. Deregulation of this protein kinase as induced by extracellular amyloid loading results in tau hyperphosphorylations, thus triggering a sequence of molecular events that lead to neuronal degeneration. Inhibitors of Cdk5 and GSK3beta and antisense oligonucleotides exert protection against neuronal death. On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease. This review is focused on the main protein aggregates responsible for neuronal death in both sporadic and familial forms of Alzheimer's disease, as well as on the alterations in the normal signaling pathways of functional neurons directly involved in neurodegeneration. The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.

Integrity signals

Registry

Crossref · 10.1016/s0188-4409(01)00316-2

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436

Show all 150 references

Research works printed but not linked: 2

Catania, 2001, Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells, Neurooncology, 3, 89
Saez, 1990, Gap junctions, In Vitro Toxicol, 3, 69

Sorted by citations

Items 301–400 of 477

Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?
González-Castañeda, R. E., Gálvez‐Contreras, A. Y., Luquín, S., & González-Pérez, Ó. (2011) · Current Signal Transduction Therapy · doi:10.2174/157436211797483949 · Cited by 12
Proteomic analysis of protein complexes in human SH-SY5Y neuroblastoma cells by using blue-native gel electrophoresis: An increase in lamin A/C associated with heat shock protein 90 in response to 6-hydroxydopamine-induced oxidative stress
Nakamura, M., Morisawa, H., Imajoh‐Ohmi, S., Takamura, C., Fukuda, H., & Toda, T. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.02.009 · Cited by 12
Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen
Andrés‐Benito, P., Vazquez-Costa, J. F., Garzón, N. C. Ñ., Colomina, M. J., Marco, C., González, L., Terrafeta, C., Domínguez, R., Ferrer, I., & Povedano, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073810 · Cited by 11
Across the boundary: The formalization of the interface between episodic memory and narrow syntax computation of human language
Shi, E. R. (2024) · Biolinguistics · doi:10.5964/bioling.14649 · Cited by 12
Surface-modified liposomal in-situ nasal gel enhances brain targeting of berberine hydrochloride for Alzheimer’s therapy: optimization and in vivo studies
Bahndare, S., Mathure, D. M., Ranpise, H. A., Salunke, M. R., & Awasthi, R. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2431908 · Cited by 11
Molecules of the Quinoline Family Block Tau Self-Aggregation: Implications Toward a Therapeutic Approach for Alzheimer's Disease
Navarrete, L. P., Guzmán, L., Martín, A. S., Saavedra, L. A., & Maccioni, R. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110995 · Cited by 11
Design of potent and selective GSK3β inhibitors with acceptable safety profile and pharmacokinetics
Lesuisse, D., Tiraboschi, G., Krick, A., Abécassis, P.-Y., Dutruc-Rosset, G., Babin, D., Halley, F., Châtreau, F., Lachaud, S., Chevalier, A., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.132 · Cited by 11
Herpes simplex virus tipo 1 como factor de riesgo asociado con la enfermedad de Alzheimer
Martín, C., Solís, L., Concha, M. I., & Carola Otth, L. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000600013 · Cited by 11
Effect of amyloid-Β (25–35) in hyperglycemic and hyperinsulinemic rats, effects on phosphorylation and O-GlcNAcylation of tau protein
Lozano, L., Guevara, J., Lefebvre, T., Ramos-Martínez, I. E., Limón, I. D., Díaz, A., Cerón, E., & Zenteno, E. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.04.001 · Cited by 11
Effect of Qingxin Kaiqiao Fang on Hippocampus mRNA Expression of the Inflammation‐Related Genes IL‐1β, GFAP, and Aβ in an Alzheimer’s Disease Rat Model
Mao, D.-D., Yang, W., Li, Y., Lin, J., Gao, S., Wang, Y., & Hu, H. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/9267653 · Cited by 11
Effects of conjugated linoleic acid on cleavage of amyloid precursor protein via PPARγ
Li, Y., Chen, Q., Wan, X., Yang, X., Liu, X., & Zhong, L. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0711-4 · Cited by 11
Enfermedad de Alzheimer: Actualización en terapia farmacológica
Patricio Fuentes, G., & Slachevsky, A. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005000200012 · Cited by 12
Mass Spectrometry-Based Metabolomic Multiplatform for Alzheimer’s Disease Research
González‐Domínguez, R., González‐Domínguez, Á., Sayago, A., & Fernández‐Recamales, Á. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_8 · Cited by 11
Cyclin-Dependent Kinase 5--A Neuronal Killer?
Guo, Q. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.50.pe36 · Cited by 11
Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
Zhong, X., Liu, M.-Y., He, M., Du, K., & Wei, M. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s138073 · Cited by 10
Personalized Medicine and Resurrected Hopes for the Management of Alzheimer’s Disease: A Modular Approach Based on GSK-3β Inhibitors
Arafa, R. K., & Elghazawy, N. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_11 · Cited by 10
Diagnostic biologique de la maladie d’Alzheimer : avancées, limites et perspectives
Malaplate, C., Desbène, C., Pillot, T., & Olivier, J. L. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.10.015 · Cited by 12
STUDYING THE ROLE OF ApoE IN ALZHEIMER'S DISEASE PATHOGENESIS USING A SYSTEMS BIOLOGY MODEL
Kyrtsos, C. R., & Baras, J. S. (2013) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720013420031 · Cited by 10
Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions
Zhang, C., Tan, R., Zhou, X., Wang, R., Wang, X., Ma, R., Chu, F., Li, Y., Yin, T., & Liu, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094651 · Cited by 9
The Gαq/phospholipase Cβ signaling system represses tau aggregation
Garwain, O., Yerramilli, V. S., Romero, K., & Scarlata, S. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109620 · Cited by 9
Neuron Growth Control by PDE Backstepping: Axon Length Regulation by Tubulin Flux Actuation in Soma
Demir, C., Koga, S., & Krstić, M. (2021) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc45484.2021.9683188 · Cited by 9
Association between excessive frontal cerebrospinal fluid and illness duration in males but not in females with schizophrenia
Molina, V., Sanz, J., Sarramea, F., Misiego, J. M., Carlos Benito, C., & Palomo, T. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.015 · Cited by 9
Cyclin S: a new member of the cyclin family plays a role in long‐term memory
Edelheit, S., & Meiri, N. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03128.x · Cited by 9
Therapeutic effect of Sinapic acid in aluminium chloride induced dementia of Alzheimer’s type in rats
Bais, S., Kumari, R., & Prashar, Y. (2017) · Journal of Acute Disease · doi:10.12980/jad.6.201704012 · Cited by 8
Role of Autophagy and Mitophagy in Neurodegenerative Disorders
Kapil, L., Kumar, V., Kaur, S., Sharma, D., Singh, C., & Singh, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230327092855 · Cited by 9
La neuroinflamación como factor detonante del desarrollo de la enfermedad de Alzheimer
Morales, I., Farias, G. A., & B, R. B. M. (2010) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272010000200007 · Cited by 8
Achillolide A Protects Astrocytes against Oxidative Stress by Reducing Intracellular Reactive Oxygen Species and Interfering with Cell Signaling
Elmann, A., Telerman, A., Erlank, H., Ofir, R., Kashman, Y., & Beit‐Yannai, E. (2016) · Molecules · doi:10.3390/molecules21030301 · Cited by 8
Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer’s Disease
Andrade, V., Wong-Guerra, M., Cortés, N., Pastor, G., González, A., Calfío, C., Guzmán‐Martínez, L., Navarrete, L. P., Ramos-Escobar, N., Morales, I., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070960 · Cited by 9
Wireless Insights Into Cognitive Wellness: A Paradigm Shift in Alzheimer’s Detection Through Ultrathin Wearable Antennas
Taher, F., Alathbah, M. A., M., M. A.-A., Alghamdi, T. A. H., Sree, M. F. A., & Fatah, S. Y. A. (2024) · IEEE Access · doi:10.1109/access.2024.3389814 · Cited by 7
Detection/quantification of amyloid aggregation in solution using the novel fluorescent benzofuranone-derivative compounds as amyloid fluorescent probes: synthesis and in vitro characterization
Abbasbeigi, S., Adibi, H., Moradi, S., Ghadami, S. A., & Khodarahmi‬, R. (2019) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-019-01599-1 · Cited by 7
Site-Specific C-Terminal Fluorescent Labeling of Tau Protein
Bryan, L. C., Awasthi, S., Li, Y., Nirmalraj, P. N., Balog, S., Yang, J., & Mayer, M. (2022) · ACS Omega · doi:10.1021/acsomega.2c06139 · Cited by 7
Identification of p10 as a neurotoxic product generated from the proteolytic cleavage of the neuronal Cdk5 activator
Chew, J., Chen, M. J., Lee, A. Y. W., Peng, Z. F., Chong, K., He, L., Bay, B., Ng, J. M. J., Qi, R. Z., & Cheung, N. S. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22864 · Cited by 7
Altered β‐Amyloid Precursor Protein Isoforms in Mexican Alzheimer’s Disease Patients
Sánchez-González, V., Ortíz, G. G., Gallegos-Arreola, P., Macías-Islas, M. Á., Arias‐Merino, E. D., Loera‐Castañeda, V., Martínez-Cano, E., Velázquez-Brizuela, I. E., Rosales‐Corral, S., Curiel-Ortega, C. R., et al. (2006) · Disease Markers · doi:10.1155/2006/347502 · Cited by 7
A graph theoretic mathematical model for Alzheimer's disease: Using a systems biology approach
Kyrtsos, C. R., & Baras, J. S. (2012) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2012.6399723 · Cited by 7
Symptomatic epilepsy
Shorvon, S. D., Andermann, F., & Guerrini, R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.016 · Cited by 7
Apoptosis: Pathways, Molecules and Beyond
Singh, N., & Bose, K. (2015) · Springer eBooks · doi:10.1007/978-3-319-19497-4_1 · Cited by 7
Role of Nitric Oxide Synthase in Normal Brain Function and Pathophysiology of Neural Diseases
Dağdeviren, M. (2017) · InTech eBooks · doi:10.5772/67267 · Cited by 7
Effect of L-NAME on AlCl3-induced toxicity in rat brain
Stevanović, I. D., Marina, J., Jelenković, A., Bokonjić, D., Colic, M., Stojanović, I. R., & Ninković, M. (2009) · Acta veterinaria · doi:10.2298/avb0903133s · Cited by 7
What Have We Learned from the Tau Hypothesis?
Maccioni, R. B., Farias, G. A., Rojo, L. E., Sekler, M. A., & Kuljiš, R. O. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_5 · Cited by 7
Recent advances in Polygonatum sibiricum polysaccharides: structural insights, bioactivities in Vitro and in Vivo, and therapeutic potential in human and animal models – A review
El-Hack, M. E. A., Rudayni, H. A., Aldhalmi, A. K., Alawam, A. S., Allam, A. A., Khan, M. M. H., & Khafaga, A. F. (2025) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2025.100958 · Cited by 6
Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?
Rojo, L. E., Gaspar, P. A., & Maccioni, R. B. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717203 · Cited by 6
β‐amyloid peptide binding protein does not couple to G protein in a heterologous Xenopus expression system
Lee, Y., Chang, D., Lee, Y., Chang, K., Kim, H., Yoon, J., Lee, S., Suh, Y., & Kaang, B. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10652 · Cited by 6
The Role of Tau Protein in Diseases
Das Bhaskar, C. (2018) · Annals of Advances in Chemistry · doi:10.29328/journal.aac.1001010 · Cited by 6
Managing Alzheimer Dementia Tomorrow
Rosenthal, T. C., & Khotianov, N. (2003) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.16.5.423 · Cited by 7
Phytoactive drugs used in the treatment of Alzheimer’s disease and dementia
Soni, A. G., Verma, A., Joshi, R., Shah, K., Soni, D., Kaur, C. D., Saraf, S., & Chauhan, N. S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03243-z · Cited by 5
Quantitative analysis of targeted lipidomics in the hippocampus of APP/PS1 mice employing the UHPLC-MS/MS method
Xiao, S., Wei, X., Han, B., Shi, X., Wei, C., Liang, R., Sun, J., Zhang, Z., Han, Z., & Shen, L. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1561831 · Cited by 9
Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer’s Disease
Zhang, J., Liu, Q., Zhang, H., Dai, M., Song, Q., Yang, D., Guorong Wu, A., & Chen, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230027 · Cited by 5
Deimination in Alzheimer’s Disease
Ishigami, A., Choi, E., Kim, Y., & Maruyama, N. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8317-5_13 · Cited by 5
Single-Channel Quantitative Multiplex Reverse Transcriptase-Polymerase Chain Reaction for Large Numbers of Gene Products Differentiates Nondemented from Neuropathological Alzheimer's Disease
Therianos, S., Zhu, M., Pyun, E. I., & Coleman, P. D. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63168-9 · Cited by 5
Pore-Forming Neurotoxin-Like Mechanism for Aβ Oligomer-Induced Synaptic Failure
Aguayo, L. G., Parodí, J., Sepúlveda, F. J., & Opazo, C. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_2 · Cited by 5
Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review
Ahmad, S. S., Younis, K., Jeandet, P., Aschner, M., & Khan, H. Z. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210811160007 · Cited by 5
Mechanical memory of excitable cells induced by mechanosensitive channel inactivation
Xie, J., Mao, F., Yang, Y., & Jiang, H. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.06.014 · Cited by 4
Neuroprotection against beta-amyloid toxicity by the novel estrogen receptor modulator STX requires convergent signaling pathways
Lee, H., Bostick, Z., Doherty, J., Swanson, T. L., Kelly, M. J., Quinn, J. F., Gray, N. E., & Copenhaver, P. F. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1670646 · Cited by 8
Halogenation of nucleic acid structures: from chemical biology to supramolecular chemistry
Nicolau, C., Requena-Ramírez, J., González‐García, J., & Bauzá, A. (2025) · RSC Chemical Biology · doi:10.1039/d5cb00077g · Cited by 4
Neuron Growth Output-Feedback Control by PDE Backstepping
Demir, C., Koga, S., & Krstić, M. (2022) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc53348.2022.9867218 · Cited by 4
Event-Triggered Control of Neuron Growth with Actuation at Soma
Demir, C., Koga, S., & Krstić, M. (2024) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc60939.2024.10644359 · Cited by 4
A concise review of synthetic xanthone derivatives for Alzheimer's disease
Ahmed, L. A., & Sharmah, H. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100256 · Cited by 4
Role of Oxidative Stress in Aβ Animal Model of Alzheimer's Disease: Vicious Circle of Apoptosis, Nitric Oxide and Age
Çeti̇n, F. (2013) · InTech eBooks · doi:10.5772/54718 · Cited by 4
Contribution of Diabetes and Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A., & Farooqui, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00019-5 · Cited by 4
Computational Study of the Allosteric Effects of p5 on CDK5–p25 Hyperactivity as Alternative Inhibitory Mechanisms in Neurodegeneration
Tammareddy, T., Keyrouz, W., Sriram, R. D., Pant, H. C., Cardone, A., & Klauda, J. B. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c02868 · Cited by 4
Detecting Selected Neurodegenerative Diseases Through Microwave Technology: Modeling and Identifying Different Stages of Alzheimer's Disease
M., M. A.-A., Hassan, M. S., & Mohamed, F. A. S. (2024) · International Youth Conference on Radio Electronics, Electrical and Power Engineering (REEPE) · doi:10.1109/reepe60449.2024.10479753 · Cited by 4
Prospected epigenetic moderators from natural sources and drug of class NSAIDS as effective treatment options to Prostate cancer
Dubey, V., Owusu-Apenten, R., Tripathi, S., Singh, U. P., & Semwal, A. (2017) · Journal of Acute Disease · doi:10.12980/jad.6.20170401 · Cited by 4
SpeedyRINGO Inhibits Calpain-Directed Apoptosis in Neurons
Yıldız, A., Korulu, Ş., & Karabay, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120652 · Cited by 4
Neuroimmune Dynamics in Alzheimer’s Disease Progression
Andrade, V., Guzmán‐Martínez, L., Vergara-Pulgar, K., & Maccioni, R. B. (2017) · InTech eBooks · doi:10.5772/intechopen.68941 · Cited by 4
Periodic Event-Triggered Boundary Control of Neuron Growth with Actuation at Soma
Demir, C., Diagne, M. L., & Krstić, M. (2024) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc56724.2024.10886842 · Cited by 3
N-nitro-L-arginine methyl ester influence on aluminium toxicity in the brain.
Stevanović, I. D., Jovanović, M., Čolić, M. J., Jelenković, A., Bokonjić, D., Ninković, M., & Stojanović, I. R. (2011) · PubMed · Cited by 3
Recent progress in CRISPR-Cas-system for neurological disorders
Mishra, S., Banerjee, S., Tiwari, B. S., & Tiwari, A. K. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.07.017 · Cited by 3
(Alkyl-ω-ol)triphenyltin(IV)-Loaded Mesoporous Silica as Biocompatible Potential Neuroprotectors: Evaluation of Inhibitory Activity Against Enzymes Associated with the Pathophysiology of Alzheimer’s Disease
Milisavljević, K. D., Milanović, Ž., Matić, J. D., Antonijević, M. R., Simić, V., Milošević, M., Kosanić, M., & Kaluđerović, G. N. (2025) · Nanomaterials · doi:10.3390/nano15120914 · Cited by 3
Loss of intramolecular electrostatic interactions and limited conformational ensemble may promote self-association ofcis-tau peptide
Barman, A., & Hamelberg, D. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24740 · Cited by 3
Neurochemical Aspects of Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_8 · Cited by 3
Alzheimer’s disease, Epidemiology, causes, diagnosis and novel treatments: A review.
Ullah, N., khan, N. M., & Ullah, W. (2015) · Cited by 3
Comparing Oxidative Stress Markers and S100B, Aβ-40 Proteins as Independent Neurological Markers in Distinguishing the Relation of Alzheimer's Disease and Diabetes Mellitus
Konukoğlu, D., Fırtına, S., Erkol, G., & Bolayırlı, M. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000146 · Cited by 3
Metabolomic Fingerprinting of Blood Samples by Direct Infusion Mass Spectrometry: Application in Alzheimer’s Disease Research
González‐Domínguez, R. (2017) · Journal of Analysis and Testing · doi:10.1007/s41664-017-0018-4 · Cited by 4
Nicotine: A Possible Neuroprotector in Brain Disorders
Alkadhi, K. A., Salim, S., & Alzoubi, K. H. (2025) · Springer eBooks · doi:10.1007/978-3-642-36202-6_178-1 · Cited by 2
In Search of Therapeutic Solutions for Alzheimer’s Disease
Ricardo, B., Faras, G., Leonel, E. C. R., & Jos, M. (2012) · InTech eBooks · doi:10.5772/34561 · Cited by 2
Neuropathology and Iron: Central Nervous System Iron Homeostasis
Texel, S. J., Xu, X., Pin, S., & Harris, Z. L. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_23 · Cited by 2
Peroxisome Proliferator-Activated Nuclear Receptors and Drug Addiction
Mascia, P., Tanda, G., Yaşar, S., Heishman, S. J., & Goldberg, S. R. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_11 · Cited by 2
DOSE L1 RETROTRANSPOSITION CAUSE NEURONAL LOSS IN NEURODEGENERA-TIVE DISORDERS?
Habibi, L., Akrami, S. M., & Shokrgozar, M. A. (2010) · Journal of Medical Hypotheses and Ideas · Cited by 2
Increased Production of the Potent Oxidant Peroxynitrite in the Serum of Obsessive-Compulsive Disorder Patients
Mahdavinia, M., Chaab, M., Kouti, L., Sayyah, M., & Zeidooni, L. (2021) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp.57324 · Cited by 2
Correction to: Metabolomic Fingerprinting of Blood Samples by Direct Infusion Mass Spectrometry: Application in Alzheimer’s Disease Research
González‐Domínguez, R. (2017) · Journal of Analysis and Testing · doi:10.1007/s41664-017-0041-5 · Cited by 2
Cyclic E2 and P4 on Alzheimer’s Disease Pathways
Wiley, T. S., & Haraldsen, J. T. (2017) · Advances in Alzheimer s Disease · doi:10.4236/aad.2017.61003 · Cited by 1
Amyloid Beta Hypothesis: Attention to β- and γ-Secretase Modulators
Korábečný, J., Špilovská, K., Soukup, O., Doležal, R., & Kuča, K. (2018) · InTech eBooks · doi:10.5772/intechopen.75629 · Cited by 1
Investigation of the Effect of Peptide p5 Targeting CDK5-p25 Hyperactivity on Munc18–1 (P67) Regulating Neuronal Exocytosis Using Molecular Simulations
Tammareddy, T., Keyrouz, W., Sriram, R. D., Pant, H. C., Cardone, A., & Klauda, J. B. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00148 · Cited by 1
Neurodegeneration Beyond Neurons: Emerging Insights from Molecular and Multi-Omics Approaches
Lualdi, M. (2026) · Biomedicines · doi:10.3390/biomedicines14030635 · Cited by 1
Tasa de mortalidad específica, según género y edad, de la enfermedad de Alzheimer en Venezuela
Mohamad, H., Alfonso, C., & Rovira, J. M. A. (2002) · Gaceta Médica de Caracas · Cited by 1
Alzheimer disease and other neurodegenerative diseases
Jenssen, S., & Kulandaivel, K. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.089 · Cited by 1
Status and Potential Therapeutic Importance of n–3 Fatty Acids in Neurodegenerative Disease
Farooqui, A. A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0543-7_7 · Cited by 1
Update on Deimination in Alzheimer’s Disease
Kondo, Y., Choi, E., Kim, Y., & Ishigami, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-58244-3_17 · Cited by 1
Physalis alkekengi L. var. francheti alleviates neuronal cell death caused by activated microglia in vitro
Park, B. H., Kwon, O. W., Kim, I. S., Lee, H. M., Roh, Y. J., Kim, M., Jo, Y., Cho, H., Park, J. K., Zhi, Z., et al. (2021) · Applied Biological Chemistry · doi:10.1186/s13765-021-00594-6 · Cited by 1
State-of-the-art Mass Spectrometry-based Approaches to Explore the Polar Metabolome: Alzheimer's Disease as a Case Study
González‐Domínguez, R., González‐Domínguez, Á., Sayago, A., & Fernández‐Recamales, Á. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781839163524-00219 · Cited by 1
Comparative Study of the Efficacy of L-Tryptophan Nanoparticles on Motor and Cognitive Behavior in an Alzheimer's Experimental Model
Furmann, M., Miri, A. L., Hosni, A. P., Kerppers, I. I., Machado‐Rodrigues, A. M., & Mascarenhas, L. P. G. (2021) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-75years-2021210408 · Cited by 1
Input Delay Compensation for Neuron Growth by PDE Backstepping
Demir, C., Koga, S., & Krstić, M. (2022) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2022.11.332 · Cited by 1
Neuron growth control and estimation by PDE backstepping
Demir, C., Koga, S., & Krstić, M. (2024) · Automatica · doi:10.1016/j.automatica.2024.111669 · Cited by 1
Vitamin E (Tocopherol): Implications in Cardiovascular Health and Neuroprotection
Parameswari, R., Anand, M. A. V., Wang, C., Babaujanarthanam, R., & Nagarajan, P. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_12 · Cited by 1
Integration of gut microbiota and metabolomics analysis to unravel the neuroprotective effects of hydroxy- α-sanshool on Alzheimer’s disease
Li, R., Chen, W., Zhang, H., Liang, Q., Wang, L., Peng, W., & Wu, C.-J. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250214 · Cited by 1
Antioxidants and their possible benefits in neurodegeneration
Jha, K. T., Chawla, V., Roy, G. S., & Chawla, P. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00024-x · Cited by 1
Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells
Rivabene, R., Visentin, S., Piscopo, P., Nuccio, C. D., Crestini, A., Svetoni, F., Rosa, P., & Confaloni, A. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213514317 · Cited by 1
The glymphatic system and Alzheimer's disease: possible connection?
Kyrtsos, C. R., & Baras, J. S. (2014) · Cited by 1
Multicompartmental High-Throughput Metabolomics Based on Mass Spectrometry
González‐Domínguez, R., González‐Domínguez, Á., Sayago, A., & Fernández‐Recamales, Á. (2020) · Neuromethods · doi:10.1007/978-1-0716-0864-7_15 · Cited by 1
Responses of the Adult SVZ to Neuronal Death and Injury
Emsley, J. G., & Macklis, J. D. (2006) · Springer eBooks · doi:10.1007/0-387-31389-3_5 · Cited by 1

Authors: Maccioni, R. B., Muñoz, J. P., & Barbeito, L.
Affiliations: University of Chile (CL)
Instituto de Investigaciones Biológicas Clemente Estable (UY)
Corresponding author: Maccioni, Ricardo B
ORCID: Maccioni, Ricardo B
Muñoz, Juan P
Barbeito, Luis
Venue: Archives of Medical Research
Publisher: Elsevier BV
Published: 2001-09
Volume: 32
Issue: 5
Pages: 367-381
ISSN: 0066-6769 (ISSN-L)
0188-4409
DOI: 10.1016/s0188-4409(01)00316-2
OpenAlex: W1985122965
Cited by: 474
References: 150
Citations by year: 2026: 8 · 2025: 12 · 2024: 24 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 30
FWCI: 2.49
Type: journal article
Language: en
Open access: green
americanae.aecid.es
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Archives of Medical Research (publishedVersion)
PubMed (publishedVersion)
Americanae (AECID Library) (submittedVersion, other-oa)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, neurodegeneration, amyloid plaques, neurofibrillary tangles, amyloid-beta, amyloid precursor protein, tau protein, tau hyperphosphorylation, cyclin-dependent kinase 5, GSK3β, oxidative stress, neuronal cell death, neuroprotective factors, estrogen, antioxidants, protein kinase inhibitors, antisense oligonucleotides, dementia
MeSH terms: Adult, Aged, alpha-Macroglobulins, Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Astrocytes, Calcium, Estrogens, Humans, Membrane Proteins, Memory Disorders, Middle Aged, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Neurotoxins, Nitric Oxide, Parkinson Disease, Protein Processing, Post-Translational, Signal Transduction, Motor Neuron Disease, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Cell Death, Age of Onset, Oxidative Stress, Neurodegenerative Diseases, Caspases, Presenilin-1, Presenilin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks